09.15.15
The worldwide market for prescription dermatological drugs exceeded $21 billion last year, growing at a rate of 7.9% from 2013 to 2015, according to a report from Kalorama Information.
In its report, “World Market for Prescription Dermatological Drugs, 9th Edition (Anti-acne, Anti-aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments),” Kalorama notes that driving forces include growth and aging of the worldwide population, new products and technologies, and focus on lifestyle treatments that improve the effects of aging and damage to the skin.
The psoriasis and skin cancer treatments dermatology drug sectors were among those that showed dramatic gain in the last two years.
Sales of prescription acne and rosacea and other drugs reflected a slower growth rate during this period because many of the drugs are older and have lost patent protection, noted the firm.
In its report, “World Market for Prescription Dermatological Drugs, 9th Edition (Anti-acne, Anti-aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments),” Kalorama notes that driving forces include growth and aging of the worldwide population, new products and technologies, and focus on lifestyle treatments that improve the effects of aging and damage to the skin.
The psoriasis and skin cancer treatments dermatology drug sectors were among those that showed dramatic gain in the last two years.
Sales of prescription acne and rosacea and other drugs reflected a slower growth rate during this period because many of the drugs are older and have lost patent protection, noted the firm.